We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Union has secured 200 million more doses of the Pfizer/BioNTech COVID-19 vaccine, with an option to buy 100 million additional doses, bringing the total number of potential doses contracted for to 600 million. Read More
Dewpoint will receive an upfront payment and potential future milestone payments totaling $239 million, plus royalties from any approved products. Read More
OBT will receive an upfront payment and additional payments for reaching discovery, clinical and regulatory goals, as well as royalties on future sales. Read More
German vaccine developer CureVac has secured a deal with Bayer to help gain regulatory approvals worldwide for its messenger RNA-based COVID-19 vaccine candidate, CVnCoV. Read More
South Africa received the discounted price because it is considered a developing nation and because the vaccine is being evaluated in a phase 3 trial in the country. Read More
Italy’s Angelini Pharma announced plans to purchase Swiss drugmaker Arvelle Therapeutics in a deal worth up to $960 million, gaining access to the epileptic seizure drug cenobamate which it plans to market in Europe. Read More
Amerisource Bergen, the second largest U.S. wholesale drug distributor, announced that it is acquiring the Walgreens Boots Alliance European distribution unit, Alliance Healthcare, in a deal valued at $6.5 billion. Read More
The U.S. government is moving ahead of schedule on a vaccine partnership with pharmacies across the country to speed up inoculations with the Pfizer/BioNTech and Moderna vaccines and it will start the program this week, HHS Secretary Alex Azar announced yesterday. Read More
Wholesale price increases for brand-name drugs analyzed by the research group 46Brooklyn outpaced inflation for the past two years with a median increase of 5 percent in both years. Read More